These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 6290719)

  • 1. [Clinical picture and geographical pathology of non-B type hepatocellular carcinoma].
    Yamada G; Mizuno M; Sakamoto Y; Nishihara T; Nagashima H
    Nihon Shokakibyo Gakkai Zasshi; 1982 Jun; 79(6):1290-7. PubMed ID: 6290719
    [No Abstract]   [Full Text] [Related]  

  • 2. The relationship between hepatitis B virus infection and hepatic cell carcinoma in Mozambique.
    Reys LL; Purcell RH; Holland PV; Alter HJ
    Trop Geogr Med; 1977 Sep; 29(3):251-6. PubMed ID: 202048
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anti-HBs reactivity in hepatitis B surface antigen positive serum samples--with special emphasis on heterotypic antibody.
    Chen DS; Lai MY; Sung JL
    Taiwan Yi Xue Hui Za Zhi; 1982 Nov; 81(11):1357-64. PubMed ID: 6298339
    [No Abstract]   [Full Text] [Related]  

  • 4. [Hepatitis-associated antigen and antibody in patients with hepatocellular carcinoma].
    Hirano Y
    Rinsho Byori; 1982 Jul; 30(7):758-63. PubMed ID: 6294381
    [No Abstract]   [Full Text] [Related]  

  • 5. Antibody to hepatitis B core antigen in patients with hepatocellular carcinoma.
    Kubo Y; Okuda K; Hashimoto M; Nagasaki Y; Ebata H
    Gastroenterology; 1977 Jun; 72(6):1217-20. PubMed ID: 192626
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Circulating immune complexes in hepatocellular carcinoma.
    Tabor E
    Cancer Invest; 1991; 9(2):241-2. PubMed ID: 1650627
    [No Abstract]   [Full Text] [Related]  

  • 7. HBeAg/anti-HBe and alpha-fetoproteins levels in primary hepatocellular carcinoma.
    Liaw YF
    Lancet; 1982 Dec; 2(8313):1458. PubMed ID: 6184587
    [No Abstract]   [Full Text] [Related]  

  • 8. [Comparative study of the humoral markers associated with hepatitis B virus in hepatocellular carcinoma patients and in subjects with chronic hepatopathy].
    de Franchis R; Primignani M; Vecchi M; Zannier PM; Colombo M; Colucci G; Antoniozzi F; Tommasini M
    Ann Sclavo; 1982; 24(1):37-48. PubMed ID: 6303232
    [No Abstract]   [Full Text] [Related]  

  • 9. Effect of cytotoxic chemotherapy on hepatitis B viral markers in patients with hepatocellular carcinoma.
    Zaman S; Melia W; Johnson P; White Y; Williams R
    Clin Oncol; 1984 Sep; 10(3):247-52. PubMed ID: 6090048
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hepatocellular carcinoma, hepatitis B and measles.
    Ree GH
    Br J Cancer; 1979 Feb; 39(2):205-6. PubMed ID: 219879
    [No Abstract]   [Full Text] [Related]  

  • 11. [Incidence of e antigen and antibody in acute and chronic HBsAg (+) liver diseases].
    San Miguel Joglar G; Rodríguez de Lope C; Pérez Fuenzalida F; Pons Romero F
    Rev Clin Esp; 1978 Jul; 150(1-2):67-9. PubMed ID: 704994
    [No Abstract]   [Full Text] [Related]  

  • 12. Hepatitis-B virus determinant in patients with liver disease in Malawi.
    Molyneux ME; Supran EM; Islam MN; Banatvala JE; Hutt MS
    Trans R Soc Trop Med Hyg; 1980; 74(3):383-8. PubMed ID: 6254218
    [No Abstract]   [Full Text] [Related]  

  • 13. [Detection of anti-HBc specific IgG/IgM in sera of hepatoma patients].
    Tsai MC; Lu CC; Liu WT
    Zhonghua Min Guo Wei Sheng Wu Ji Mian Yi Xue Za Zhi; 1980 Dec; 13(4):361-9. PubMed ID: 6262027
    [No Abstract]   [Full Text] [Related]  

  • 14. A controlled study of hepatitis core antibody (HBcAb) in primary hepatocellular carcinoma and liver cirrhosis in Kenya.
    Bowry TR; Shah MV; Ahmad Z
    East Afr Med J; 1981 Aug; 58(8):576-82. PubMed ID: 6271520
    [No Abstract]   [Full Text] [Related]  

  • 15. HBeAg/anti-HBe system and development of primary hepatocellular carcinoma in patients with HBsAg-positive liver cirrhosis.
    Musca A; Cordova C; Barnaba V; Bonavita MS; Levrero M; Zaccari C; Balsano F
    Hepatogastroenterology; 1983 Feb; 30(1):3-5. PubMed ID: 6299916
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Relationship between primary carcinoma of the liver and Australia antigen or anti-Australia HB antigen in Greece].
    Theodoropoulos G; Economopoulos P; Archimandritis A; Melissinos K
    Nouv Presse Med; 1977 Feb; 6(8):654. PubMed ID: 866166
    [No Abstract]   [Full Text] [Related]  

  • 17. HBV-DNA in sera of patients with HBsAg-positive primary liver cell carcinoma.
    Theilmann L; Gmelin K; Will H; Czygan P; Hasche G; Doerr HW; Kommerell B
    Z Gastroenterol; 1984 Apr; 22(4):182-7. PubMed ID: 6328781
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A serological study on primary hepatocellular carcinoma in Zambia.
    Zumla A; Voller A
    Trans R Soc Trop Med Hyg; 1982; 76(4):546-51. PubMed ID: 6190277
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A high prevalence of antibody to the hepatitis C virus in patients with hepatocellular carcinoma in Japan.
    Nishioka K; Watanabe J; Furuta S; Tanaka E; Iino S; Suzuki H; Tsuji T; Yano M; Kuo G; Choo QL
    Cancer; 1991 Jan; 67(2):429-33. PubMed ID: 1845946
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hepatitis B viral markers in patients with primary hepatocellular carcinoma in Taiwan.
    Chien MC; Tong MJ; Lo KJ; Lee JK; Milich DR; Vyas GN; Murphy BL
    J Natl Cancer Inst; 1981 Mar; 66(3):475-9. PubMed ID: 6162990
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.